AG00I5IO

298-81-7 | 9-methoxy-2H-furo[3,2-g]chromen-2-one

AG00I5IO

SDS

COA

Price

$0.00

WARNING This product is not for human or veterinary use.

CAS Number	298-81-7
Catalog Number	AG00I5IO(AGN-PC-03GQ5Q)
Chemical Name	9-methoxy-2H-furo[3,2-g]chromen-2-one
EC Number	206-066-9
IUPAC Name	9-methoxyfuro[3,2-g]chromen-7-one
InChI	InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3
InChI Key	QXKHYNVANLEOEG-UHFFFAOYSA-N
MDL Number	MFCD00005009
Molecular Formula	C12H8O4
Molecular Weight	216.1895
SMILES	COC=1C2=C(C=C3C=CC(OC13)=O)C=CO2
UN Number	1759
UNII	U4VJ29L7BQ
Synonyms	8 Methoxypsoralen, 8 MOP, 8-Methoxypsoralen, 8-MOP, 8MOP, Ammoidin, Deltasoralen, Dermox, Geroxalen, Méladinine, Meladinina, Meladinine, Meloxine, Methoxa Dome, Methoxa-Dome, Methoxsalen, Oxsoralen, Oxsoralen Ultra, Oxsoralen-Ultra, Puvalen, Ultramop, Xanthotoxin, methoxsalen, 8-Methoxypsoralen, XANTHOTOXIN, 298-81-7, Meladinine, Ammoidin, Oxsoralen, Meloxine, Oxypsoralen, Xanthotoxine, 8-MOP, Meladinin, Puvalen, 9-Methoxy-7H-furo[3,2-g]chromen-7-one, Meladoxen, Ammodin, Uvadex, Methoxa-Dome, 8-Methoxypsoralene, New-Meladinin, Geroxalen, Oxsoralen-ultra, Methoxalen, Puvamet, Oxsoralen Ultra, Oxsoralen lotion, 9-Methoxypsoralen, Zanthotoxin, Psoralon-MOP, Proralone-mop, 8-MP, 8-Methoxyfuranocoumarin, Meladinin (VAN), 9-methoxyfuro[3,2-g]chromen-7-one, Dltasoralen, Methoxsalene, Methoxaten, Metoxaleno, Oxoralen, 8-Methoxy-2',3',6,7-furocoumarin, Psoralen-mop, NCI-C55903, Ultra Mop, 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one, 8-Methoxy-4',5',6,7-furocoumarin, O-methylxanthotoxol, 7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-, Methoxy-8-psoralen, 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone, UNII-U4VJ29L7BQ, 9-Methoxyfuro[3,2-g][1]benzopyran-7-one, NSC45923, MFCD00005009, NSC 45923, 9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one, CCRIS 2083, HSDB 2505, 8-Methoxy-(furano-3'.2':6.7-coumarin), 8-Methoxy-[furano-3'.2':6.7-coumarin], 8-Methoxypsoralen with ultraviolet A therapy, Methoxsalen (Oxsoralen), EINECS 206-066-9, 9-Methoxyfuro(3,2-g)chromen-7-one, Methoxsalen plus ultraviolet radiation, 8-Methoxy-4',5':6,7-furocoumarin, CHEMBL416, 7H-Furo(3,2-G)(1)benzopyran-7-one, 9-methoxy-, BRN 0196453, U4VJ29L7BQ, 8-Methoxy-6,7-furanocoumarin, 9-Methoxy-7H-furo(3,2-g)benzopyran-7-one, 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone, CHEBI:18358, 9-(methyloxy)-7H-furo[3,2-g]chromen-7-one, QXKHYNVANLEOEG-UHFFFAOYSA-N, 9-methoxyfurano[3,2-g]chromen-2-one, NCGC00016418-07, AK111265, CAS-298-81-7, ST041029, DSSTox_CID_830, 8-Methoxypsoralen, 99%, EN300-52504, DSSTox_RID_75816, 9-METHOXY-2H-FURO[3,2-G]CHROMEN-2-ONE, DSSTox_GSID_20830, 8MO, Q-100381, Deltapsoralen, Ultramop Lotion, Methoxsalen [BAN:JAN], 7-Furocoumarin, Oxsoralen Ul tra, 8-Methoxy, Methoxsalen, 8-, CPD000071170, SMR000071170, OXSORALEN (TN), SR-01000629727, Vitpso, Methoxsalen [USP:BAN:JAN], Prestwick_661, Methoxsalen(Oxsoralen), Methoxsalen with ultra-violet A theraphy, Spectrum_001023, 8-MOP ; Methoxsalen, 5-Demethoxyisoimpinellin, 8-Methoxy(furano-3'.2':6.7-coumarin), AC1L1HFY, Prestwick0_000479, Prestwick1_000479, Prestwick2_000479, Prestwick3_000479, Spectrum2_001052, Spectrum3_000499, Spectrum4_000052, Spectrum5_001891, UVADEX (TN), 9-metho xy-7H-furo(3,2-g)benzopyran-7-one, Methoxsalen (JP17/USP), 7H-Furo[3, 9-methoxy-, Oprea1_166319, SCHEMBL19168, BSPBio_000618, BSPBio_001997, KBioGR_000543, KBioSS_001503, 5-19-06-00015 (Beilstein Handbook Reference), MLS000062633, MLS002303011, DivK1c_000763, SPECTRUM1500400, SPBio_001004, SPBio_002557, 8-METHOXYPSORALEN + UVA (SEE ALSO C55903), BPBio1_000680, MEGxp0_000095, Jsp005650, Xanthotoxin, analytical standard, DTXSID8020830, ACon1_000174, HMS502G05, KBio1_000763, KBio2_001503, KBio2_004071, KBio2_006639, KBio3_001497, 8-Methoxy-2',6,7-furocoumarin, 8-Methoxy-4',6,7-furocoumarin, NINDS_000763, HMS1569O20, HMS1920N05, HMS2091D20, HMS2096O20, HMS2269P03, HMS3259L13, HMS3655B05, LS-68, Pharmakon1600-01500400, 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone, BCP28212, ZINC2548959, Tox21_110432, Tox21_201767, Tox21_302816, BDBM50041234, BG0479, CCG-36366, CM-131, GP5578, NSC-45923, NSC757114, s1952, SBB005950, STK735539, WLN: T C566 DO LVOJ BO1, 8-Methoxypsoralen, analytical standard, AKOS000277012, Tox21_110432_1, AC-4259, AM84906, API0008254, CS-1983, DB00553, DS-5159, JC10026, MCULE-2500932325, NC00652, NSC-757114, SDCCGMLS-0042377.P002, IDI1_000763, KS-00000J91, 8-methoxy-2'',3'',6,7-furocoumarin, 8-methoxy-4'',5'':6,7-furocoumarin, NCGC00016418-01, NCGC00016418-02, NCGC00016418-03, NCGC00016418-04, NCGC00016418-05, NCGC00016418-06, NCGC00016418-08, NCGC00016418-09, NCGC00016418-10, NCGC00016418-11, NCGC00016418-12, NCGC00016418-14, NCGC00016418-15, NCGC00060938-02, NCGC00060938-03, NCGC00060938-04, NCGC00060938-05, NCGC00060938-06, NCGC00178871-01, NCGC00178871-02, NCGC00178871-03, NCGC00256435-01, NCGC00259316-01, 4CN-0934, AJ-39565, AN-12178, BC204608, CC-30277, HY-30151, NCI60_004085, Q039, SAM002548974, SAM002564221, SC-13812, SBI-0051443.P003, AB2000388, AX8020056, BC4157549, FT-0082222, FT-0602101, N1305, ST24045871, SW167762-4, 8-methoxy-[furano-3''.2'':6.7-coumarin], 9-Methoxy-7H-furo[3,2-g]chromen-7-one #, C01864, D00139, J10204, AB00052042-14, AB00052042-15, AB00052042_16, AB00052042_17, 298M817, 9-Methoxy-7H-furo[3,2- g][1]benzopyran-7-one, C-11618, I06-0695, SR-01000629727-2, SR-01000629727-4, BRD-K63430059-001-03-2, BRD-K63430059-001-06-5, BRD-K63430059-001-09-9, Z1258578369, A1783/0075596, Xanthotoxin;Metoxaleno; Dltasoralen;Meladinine;Uvadex,;Oxsoralen, Methoxsalen, United States Pharmacopeia (USP) Reference Standard, Xanthoxin, Deltasoralen, Meladinina, Ultramop, Dermox, Methoxa Dome, 8 Methoxypsoralen, 8-MOP Capsules, 8-methoxyfurocoumarins, 8MOP, Methoxsalen Delta Brand, 8-methoxyfuranocoumarins, an 8-methoxyfurocoumarin, DB Brand of Methoxsalen, Methoxsalen Canderm Brand, Methoxsalen Chinoin Brand, D08SKH, Delta Brand of Methoxsalen, Methoxsalen Dermatech Brand, Methoxsalen (JP15/USP), 8 MOP, Canderm Brand of Methoxsalen, Chinoin Brand of Methoxsalen, ICN Brand 1 of Methoxsalen, ICN Brand 2 of Methoxsalen, ICN Brand 3 of Methoxsalen, Galderma Brand of Methoxsalen, Methoxsalen Mex-America Brand, Methoxsalen [INN:BAN:JAN], C12H8O4, Dermatech Brand of Methoxsalen, Mex America Brand of Methoxsalen, Mex-America Brand of Methoxsalen, CID4114, Benzyl trimethyl ammonium chloride, Methoxsalen Sanofi-Synthelabo Brand, DRG-0088, C12-H8-O4, NA1759, UN1759, Sanofi Synthelabo Brand of Methoxsalen, Sanofi-Synthelabo Brand of Methoxsalen, ACN-035428, CS-O-01892, X0009, Boehringer Ingelheim Brand of Methoxsalen, 5-Benzofuranacrylic acid, .delta.-lactone, A10578, 7H-Furo[3,2-g][1]benzopiran-7-ona, 9-metoxi-, D008730, 8-Methoxypsoralen (Methoxsalen) plus ultraviolet A radiation, 2-[(4-butyl-1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)thio]-N-(2-fluorophenyl)acetamide, 56-93-9, Xanthotoxin, 98%, a potent tricyclic furocoumarin suicide inhibitor of CYP (cytochrome P-450) - 1G 1g,

Complexity	325
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	216.042g/mol
Formal Charge	0
Heavy Atom Count	16
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	216.192g/mol
Monoisotopic Mass	216.042g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	48.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	1.9

GHS Hazard and Precautionary Statements

Symbol:
Hazard statements	H302-H317
Precuationary statements	P280-P301+P312+P330-P261-P280g-P301+P312a-P321-P333+P313-P501a
Siginal words

Certificate of Analysis

Lot Number